Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG Inhalation for Interstitial Pneumonia in Cancer Patients
NCT05758571Phase 2Recruiting
- Sponsor
- Shandong Cancer Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epigallocatechin gallate in interstitial pneumonia, sponsored by Shandong Cancer Hospital. Started Jan 2023; status: recruiting.
02
Drugs
epigallocatechin gallate
03
Conditions
interstitial pneumonia
Beyond the preview
Go deeper on NCT05758571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05758571.